Pharmather

Published October 4, 2026 · Updated October 5, 2026

Strategic Assets | PharmaTher

Read the full story at Pharmather

Ketamine ANDA. PharmaTher's FDA-approved ketamine ANDA, sold in December 2025, has the potential to generate more than US$25 million over time,.